Market Research Reports and Industry Reports

Cosmo Pharmaceuticals NV (COPN) - Medical Equipment - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix (MMX) technology. Its proprietary clinical development pipeline intended for the treatment of various gastro-intestinal tract, inflammatory bowel diseases, colon infections and colon diagnosis. Cosmo also offers SIC 8000, a submucosal injectable composition for extracting polyps and adenomas; and other products. The company manufactures products for oral administration such as tablets, capsules, powders and syrups; topical dosage forms such as emulsions, gels, ointments and others; and injectables. Its manufacturing facility is located in Lainate, Milan. Cosmo is headquartered in Dublin, Ireland.

Cosmo Pharmaceuticals NV (COPN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cosmo Pharmaceuticals NV, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Cosmo Pharmaceuticals NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cosmo Pharmaceuticals NV, Medical Equipment, Deal Details 10
Partnerships 10
Cosmo Pharmaceuticals Enters into Agreement with FujiFilm Europe 10
Cosmo Pharma Enters into Co-Promotion Agreement with Olympus America 11
Equity Offering 12
Cosmo Pharma Raises USD215.5 Million in Private Placement of Shares 12
Cosmo Pharma Raises USD103.4 Million in private placement of Shares 13
Cosmo Pharmaceuticals NV - Key Competitors 14
Cosmo Pharmaceuticals NV - Key Employees 15
Cosmo Pharmaceuticals NV - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Jul 29, 2016: Cosmo Reports Growth In Product Revenues And Progress In Late Stage Product And Corporate Development 17
Mar 23, 2016: Record Profits for Cosmo in 2015 19
Corporate Communications 20
Jun 01, 2017: Cosmo appoints new Head of Investor Relations 20
May 17, 2017: Cosmo Pharmaceuticals Announces Appointment Of Non-Executive Board Member 21
Product News 22
Nov 10, 2016: Cosmo Announces Successful Outcome of phase III clinical trial for LuMeBlue 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables

List of Tables
Cosmo Pharmaceuticals NV, Medical Equipment, Key Facts, 2016 2
Cosmo Pharmaceuticals NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cosmo Pharmaceuticals NV, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cosmo Pharmaceuticals NV, Deals By Market, 2011 to YTD 2017 8
Cosmo Pharmaceuticals NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cosmo Pharmaceuticals Enters into Agreement with FujiFilm Europe 10
Cosmo Pharma Enters into Co-Promotion Agreement with Olympus America 11
Cosmo Pharma Raises USD215.5 Million in Private Placement of Shares 12
Cosmo Pharma Raises USD103.4 Million in private placement of Shares 13
Cosmo Pharmaceuticals NV, Key Competitors 14
Cosmo Pharmaceuticals NV, Key Employees 15
Cosmo Pharmaceuticals NV, Subsidiaries 16

Cosmo Pharmaceuticals NV (COPN) - Medical Equipment - Deals and Alliances Profile

Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix (MMX) technology.

USD 250View Report

Angelo Farrell – Royal Cosmopolitan Mixed-Use Development – Louisiana - Project Profile

Synopsis Angelo Farrell Royal Cosmopolitan Mixed-Use Development Louisiana - Project Profile contains information on the scope of the project including project overview and location. The profile also details project

USD 75View Report

Cosmo Pharmaceuticals S.p.A Strategic Analysis Review- Cosmo Pharmaceuticals S.p.A SWOT, Outlook, Operations and Financial Profile

Cosmo Pharmaceuticals S.p.A Company Profile provides strategic analysis of Cosmo Pharmaceuticals S.p.A Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200View Report

Cosmo Pharmaceuticals NV (COPN) - Financial and Strategic SWOT Analysis Review

Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix (MMX) technology.

USD 300View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Dec 2017
No. of Pages :23
Country :Ireland
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube